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Screening for asymptomatic hypertension is routinely under-
taken in primary care settings and was recently advocated by the 
Society for Academic Emergency Medicine and the American 
College of Emergency Physicians to be conducted by emer-
gency medicine providers.1,2 These endorsements are based, in 
part, on the potential long-term public health benefits and the 
minimal effort required by emergency department (ED) staff to 
screen and refer patients with elevated blood pressure (BP) to 
outpatient management. Universal  screening has the potential to 
improve long-term health outcomes of ED patients, particularly 
the at-risk patient populations. Hypertension and its associated 
morbidity affects higher rates of blacks, the socioeconomically 
disadvantaged and the elderly, groups that are disproportion-
ately represented in national ED utilization estimates, and there-
fore, most likely to benefit from ED-based screening efforts.3–8
The available literature on ED-based hypertension screening 
is focused primarily on patient characteristics and demonstrates 
insufficient screening and referral rates (7–45%).9–12 However, 
to improve screening and referral efforts, additional informa-
tion is required of health-care providers. Specifically, what 
are health-care provider goals, how do they rate their screen-
ing and referral efforts, and how does self-report  compare to 
actual practice? To our knowledge, no such study exists. Thus, 
we initiated a multicenter investigation  comparing health-care 
provider self-reported practice patterns to actual practice and 
endeavored to determine whether a disconnect exists.
Methods
Study population. A retrospective cohort of 1,250 adult ED 
patients with elevated BP was selected from five institutions. 
Patients aged ≥18 years, presenting with an initial systolic BP 
(SBP) ≥140 mm Hg or diastolic BP (DBP) ≥90 mm Hg, and dis-
charged from the ED were eligible for inclusion. Patients who were 
pregnant, had a repeat visit during the sampling period, or were 
evaluated by a nonemergency medicine resident were excluded.
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Background
We attempted to identify patient factors associated with blood 
pressure (BP) reassessment and to compare health-care provider 
self-reported reassessment and referral to actual practice in an 
emergency department (eD) setting.
Methods
Provider reassessment and referral practices were determined through 
systematic review of 1,250 medical records at five eDs. Medical records 
were included if patients were ≥18 years, nonpregnant, presented with 
a systolic (SBP) ≥140 or diastolic BP (DBP) ≥90 mm Hg, and discharged. 
A separate questionnaire obtained self-reported practice patterns of 
health-care providers. Multivariate logistic regression identified factors 
associated with patient BP reassessment and referral.
results
Of 1,250 patients, only 57% underwent BP reassessment and 
9% received a referral for outpatient management. The most 
significant independent variables related to a reassessment were 
as follows: treatment of elevated BP in the eD (odds ratio (OR): 6.05; 
95% confidence interval (CI): 1.80–20.31), chest pain (OR: 3.90; 
95% CI: 2.37–6.42), and presence of an eD reassessment protocol 
(OR: 2.49; 95% CI: 1.77–3.50). The most significant factors associated 
with a referral included treatment of elevated BP in the eD 
(OR: 5.55; 95% CI: 2.72–11.32), presence of a reassessment protocol 
(OR: 2.58; 95% CI: 1.32–5.05), and a BP reassessment (OR: 2.56; 95% 
CI: 1.34–4.89). For self-reported practice patterns, 379 (72%) health-
care providers completed questionnaires. Providers consistently 
overestimated their referral practices, yet the mean referral 
threshold values reported (SBP, 150 mm Hg; DBP, 93 mm Hg) were 
lower than the mean BP values of patients who actually received a 
directed referral (SBP, 170 mm Hg; DBP, 97 mm Hg, P < 0.0001).
conclusions
Reassessment and referral of discharged eD patients with elevated 
BP was infrequent and health-care providers overestimate their 
reassessment and referral efforts.
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Medical record sampling was conducted over a 6–8 week 
period immediately preceding the administration of the 
health-care provider questionnaire. This limited sampling 
period was instituted to minimize bias and allow compari-
sons in current health-care provider practices and self-report. 
Sampling was conducted during two calendar months, on 
alternating days and every other eligible patient was enrolled. 
This ensured a high yield in physician documentation, captur-
ing two rotations of emergency medicine residents and a high 
proportion of attending physicians. A maximum of 30 records 
were included from each day until 250 records were reviewed 
and all days of the week were represented.
Ninety-six percent of all ED health-care providers docu-
mented on at least one medical record included in the above 
cohort, leaving 97 attending physicians, 99 residents, and 328 
nurses (n = 524) eligible to participate in a prospective cross-
sectional survey on practice patterns. Eligible health-care 
providers were asked to complete questionnaires about their 
reassessment, management and referral of ED patients with 
elevated BP. To minimize changes in health-care provider prac-
tice patterns, questionnaires were distributed after the medical 
record review at each site, and all providers were blinded to the 
medical record review.
Of the five EDs that participated in this investigation, four 
were urban, academic centers with emergency medicine resi-
dents. The annual census for these four sites ranged from 
49,000 to 120,000, with a total combined annual census of 
327,000. The fifth ED was in a suburban setting with an annual 
census of 38,000 and did not have residents. Data collection 
was initiated in November 2005 and completed in June 2006. 
The retrospective portion of the study was approved by each 
participating site’s institutional review board, and waivers of 
written consent for the health-care providers were granted.
Medical record abstraction. Patient demographics were 
obtained from the medical record, with race and ethnicity self-
identified during patient registration. Presence of pain, his-
tory of hypertension, use of antihypertensive medications, and 
current alcohol or cocaine use were noted. Patients presenting 
with symptoms of chest pain, shortness of breath, or neuro-
logic complaints, including focal weakness, sensory changes, 
disequilibrium, vision changes, and headache, were considered 
symptomatic in this review.
For each patient, the initial BP measurement and up to two 
subsequent reassessments, if available, were recorded. At all 
sites, patient’s initial BP was obtained by a triage nurse using 
an electronic sphygmomanometer. Subsequent measure-
ments were obtained using electronic sphygmomanometers 
by nurses, technicians, or physicians, per departmental policy. 
Although each site had protocols in place for standardized BP 
measurements (i.e., the use of appropriately sized cuffs and the 
completion of measurements in patients who were resting qui-
etly), no attempts were made to enforce or ascertain compli-
ance with these policies. Any attempt to do so may have led to a 
loss of blinding of health-care providers. Only two sites had BP 
reassessment protocols in place: One required a  reassessment 
every 4 h and the second required a reassessment if a patient’s 
BP was >140/90 mm Hg and a final reassessment of all patients 
at discharge.
Discharge instructions were reviewed for directed medical fol-
low-up. All sites had discharge instructions containing generic 
referrals to a primary care physician or a clinic for further medi-
cal care. To meet the definition of a directed referral, follow-up 
instructions had to (i) specifically note that the patient had ele-
vated BP in the ED; (ii) note the elevated BP reading(s); or (iii) 
state that the patient needed reassessment for high BP or hyper-
tension. Discharge instructions were additionally reviewed for 
instructions in lifestyle modification and for the provision of a 
prescription for antihypertensive medication(s).
BP categorization. To facilitate patient categorization, we used 
the ranges provided by the seventh Joint National Committee 
on Prevention, Detection, Evaluation, and Treatment of high 
BP report staging for adults aged ≥18 years, with stage 1 (SBP 
140–159 mm Hg or DBP 90–99 mm Hg) and stage 2 (SBP ≥ 
160 mm Hg or DBP ≥100 mm Hg). This somewhat artificial 
categorization was necessary to facilitate presentation of the 
data. It was not our intention to suggest that patients with BPs 
falling within these ranges to have stage 1 or 2 hypertension. 
Furthermore, no attempt was made to use the lower BP values 
suggested for diabetics because this history was inconsistently 
recorded in the medical record, and, again, our goal was not to 
conduct hypertension staging.13
Health-care provider questionnaire. Health-care providers pro-
vided demographic information including professional degree 
and years of practice (attending physicians and nurses) or 
training (residents). To assess reassessment practices, health-
care providers were asked what initial SBP and DBP would 
prompt them to obtain a repeat measurement and when they 
would “routinely refer” low acuity, asymptomatic patients for 
outpatient BP reassessment and management. “Low acuity” 
was defined as a single minor complaint (e.g., sprain or simple 
laceration). Physicians were also asked to note what BP read-
ing would lead them to prescribe lifestyle and dietary modifi-
cations or an antihypertensive medication at discharge.
Outcome measures. There were two primary outcomes in this 
investigation: (i) the proportion of patients who underwent BP 
reassessment as per the medical record compared to health-
care provider self-report and (ii) the proportion of asympto-
matic patients who received an outpatient referral compared 
to health-care provider self-report. Secondary outcomes 
included the frequency of lifestyle modification recommenda-
tions, including low-salt diet, increased exercise, avoidance of 
alcohol or cocaine, and the provision of a prescription for an 
antihypertensive medication. For secondary outcomes, prac-
tice, as evidenced by medical record review, was compared to 
health-care provider self-report.
Statistical analysis. Data were analyzed using SPSS version 
15.0 (SPSS, Chicago, IL). Patient characteristics are presented 
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as either percentages or mean ± s.d. Univariate analysis was 
conducted using Student’s t-test and χ2 or Fisher’s exact test 
where appropriate. Multivariable logistic regression explored 
the effect of patient and site characteristics on the likelihood of 
patients receiving a BP reassessment and an outpatient refer-
ral. A “best fit” model was developed by using forced entry and 
then backward elimination. Patient referral as per the medi-
cal record is presented as the percentage of patients who were 
given a directed referral with 95% confidence intervals (CIs). 
Health-care provider self-report for referral is presented as 
mean percentages with 95% CIs. All analyses were two-tailed 
and P values <0.05 were considered statistically significant.
results
Of the 7,293 screened ED medical records, 6,043 were excluded 
for the following reasons: initial BP did not meet study cri-
teria (n = 2,995); patient <18 years (n = 1,450); patient was 
 admitted (n = 1,423); patient care was provided by a nonemer-
gency medicine resident (n = 132); and patient was pregnant 
(n = 43). The remaining 1,250 records met study criteria and 
were included in the final analyses.
reassessments
Repeat BP assessments occurred in 709 (57%) and a third 
assessment in 419 (34%). Of patients with repeat BP measure-
ments, 476 (67%) remained elevated with the second measure-
ment. Sixty-six (5%) patients presented with two symptoms 
and five (0.4%) with three. Patient characteristics are pre-
sented in Table 1. To identify factors associated with a BP reas-
sessment, multivariate analyses were performed. For patients 
with BPs within stage 1 values, pharmaceutical treatment of 
elevated BP, presentation with chest pain, and presence of a 
BP reassessment protocol were the three factors most highly 
associated with a BP reassessment. In the group with initial 
BPs corresponding to stage 2 values, the presence of a reas-
sessment protocol was not as highly associated with a BP reas-
sessment. Rather, chest pain and neurologic complaints were 
the two other prominent factors. These results are presented 
in Table 2.
For the health-care provider questionnaire on practice pat-
terns, 379 (72%) of eligible providers participated, with 155 of 
196 (79%) physicians and 224 of 328 (68%) nurses completing 
questionnaires. Reassessment practices of health-care provid-
ers are presented in Table 3, where provider self-reported val-
ues are compared to the initial BPs obtained from the medical 
record review. There were 882 (71%) asymptomatic patients 
in this cohort, of whom 240 (27%) had an SBP or DBP that 
met or exceeded the highest threshold reported by health-care 
providers (SBP 170 mm Hg and DBP 100 mm Hg). Of these 
240 patients, only 155 (65%) underwent a reassessment (as 
opposed to an anticipated 100%).
referrals
Referral practices were obtained from 215 of 224 (96%) 
nurses and 149 of 155 (96%) physicians. Medical record 
review demonstrated that only 110 (9%) patients from the 
entire sample received a directed referral, and of those, 45 
were  symptomatic. Health-care providers overestimated their 
referral practices: The mean referral threshold values reported 
(SBP, 150 mm Hg; DBP, 93 mm Hg) were lower than the mean 
BP values of patients who actually received a directed referral 
(SBP, 170 mm Hg; DBP, 97 mm Hg), P < 0.0001. The discrep-
ancy between physician self-reported referral practices (in 
mean percent) and actual practice (proportion of patients who 
actually received a referral) is further delineated in Figure 1, 
and factors associated with an outpatient referral are presented 
in Table 4.
Dietary and lifestyle recommendations at discharge are pre-
sented in Table 5. Of the nine patients who received a prescrip-
tion in the lower BP group, eight had a history of hypertension. 
Of the 31 patients who received a prescription in the higher BP 
group, 23 had a history of hypertension. Overall, patients with 
a history of hypertension were more likely to have been given 
a prescription for an antihypertensive medication than those 
without (P ≤ 0.005).
discussion
To our knowledge, this is the first study to compare health-
care provider self-reported reassessment and referral of 
patients with elevated BP to actual practice in an ED setting. 
In addition, our model for BP reassessment expanded on ear-
lier investigations, incorporating previously demonstrated 
patient-level variables, such as BP and age, in addition to site 
table 1 | Patient characteristics
Entire sample (n = 1,250)
Male (%) 645 (52)
Age, mean (s.d.) 46.9 (16.6)
Black (%) 434 (35)
Hispanic (%) 179 (14)
Self-pay or charity carea 452 (37)
Triage SBP, mean (s.d.) 156 (18)
Triage DBP, mean (s.d.) 91 (13)
Triage SBP ≥140 mm Hg (%) 1,142 (91)
Triage DBP ≥90 mm Hg (%) 684 (55)
Complaint of pain at presentation (%) 896 (72)
Symptomatic: neurologic complaint, 
chest pain, and shortness of breath (%)
368 (29)
 neurologic (%) 182 (15)
 Chest pain (%) 146 (12)
 Shortness of breath (%) 116 (9)
Medical and social history
 History of hypertension (%) 436 (35)
 Currently taking antihypertensive  
 medication (%)
328 (26)
 Current alcohol use (%) 259 (21)
 Current cocaine use (%) 38 (3)
DBP, diastolic blood pressure; SBP, systolic blood pressure.
aInsurance status was missing for 35 medical records; percentage noted is valid percent.
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and provider-level characteristics, which have not been suffi-
ciently addressed.9–12,14–16
Our screening of 7,293 medical records yielded 1,250 
patients with elevated BP. This number is likely an under-
estimate for the prevalence of elevated BP in the ED patient 
population because we did not collect BP data on patients 
who were admitted, seen by a nonemergency medicine resi-
dent, or those who were under 18 years of age. Nevertheless, 
our findings are consistent with previous investigations, where 
the proportion of ED patients with elevated BP ranged from 
3 to 45%.10–12,16–20 We are well aware that these proportions 
cannot be construed as prevalence estimates of hypertension 
because compliance with standardized measurements is infre-
quently enforced and serial measurements are inconsistently 
obtained.13,21–28 In spite of these limitations, a growing body of 
literature suggests that a significant proportion of ED patients 
with elevated BP (SBP ≥140 or DBP ≥90 mm Hg) are indeed 
hypertensive, with between 26 and 77% remaining hyperten-
sive at outpatient follow-up.13,15–18,29 Based on these estimates, 
the prevalence of hypertension in ED patients falls between 1 
and 35%. With an estimated 119 million annual ED visits, a 
prevalence as low as 1% would account for over one million 
uncontrolled hypertensive patients who could potentially ben-
efit from outpatient intervention. A conservative estimate of 
10% would yield nearly 12 million.8
Our logistic regression analysis revealed several patient 
characteristics associated with a BP reassessment. Two fac-
tors, increasing age and BP elevation, have been associated 
with repeat assessments in previous studies.9–12,14–16,30 In the 
BP group corresponding to stage 1 values, chest pain and pres-
ence of a reassessment protocol were also positively associ-
ated with a BP reassessment. An unexpected finding, however, 
was that patients in the lower BP ranges who were primarily 
cared for by an attending physician also had higher odds of a 
repeat assessment. This is somewhat counterintuitive because 
physical examination documentation by trainees tends to be 
more comprehensive than the documentation by attending 
physicians alone.31–33 In the group corresponding to stage 
2 BP values, chest pain and presence of a reassessment proto-
col remained positively associated with a reassessment. Unlike 
the lower BP group, however, neurologic complaints, increas-
ing SBP and DBP values, and pharmacologic treatment in the 
ED also demonstrated a positive association with reassess-
ments. These differing associations between BP groups suggest 
table 2 | Factors associated with a blood pressure reassessment
Variable
All patients (n = 1,250)
SBP 140–159 mm Hg or  
DBP 90–99 mm Hg (n = 747)
SBP ≥160 mm Hg or  
DBP ≥100 mm Hg (n = 503)
Adjusted odds 
ratio (95% CI) P value
Adjusted odds 
ratio (95% CI) P value
Adjusted odds 
ratio (95% CI) P value
Demographic factors
 Female sex 1.04 (0.79–1.36) 0.45 1.12 (0.78–1.60) 0.55 1.01 (0.62–1.63) 0.99
 Age, per 10 years 1.32 (1.21–1.45) <0.0001 1.24 (1.10–1.41) 0.001 1.42 (1.20–1.67) <0.0001
 Blacka 0.52 (0.38–0.72) <0.0001 0.40 (0.26–0.61) <0.0001 0.78 (0.46–1.31) 0.35
 Hispanic ethnicity 0.86 (0.56–1.32) 0.49 0.64 (0.37–1.10) 0.10 2.22 (0.92–5.35) 0.08
History of hypertension 0.61 (0.05–7.05) 0.69 0.81 (0.05–9.43) 0.71 0.85 (0.06–11.76) 0.91
Currently taking antihypertensive 
medication
1.00 (0.97–1.02) 0.67 0.82 (0.35–1.88) 0.63 1.00 (0.97–1.03) 0.85
Alcohol use 1.00 (0.99–1.00) 0.32 0.99 (0.99–1.01) 0.16 1.00 (0.99–1.01) 0.78
Cocaine use 1.00 (0.99–1.00) 0.59 1.00 (0.99–1.00) 0.93 0.99 (0.99–1.01) 0.42
Symptomsb
 Chest pain 3.90 (2.37–6.42) <0.0001 4.37 (2.28–8.40) <0.0001 4.29 (1.69–10.92) 0.002
 Shortness of breath 1.28 (0.79–2.09) 0.23 1.05 (0.57–1.96) 0.87 1.88 (0.75–4.71) 0.18
 neurologic complaint 1.97 (1.32–2.94) 0.002 1.65 (0.97–2.85) 0.07 2.42 (1.22–4.81) 0.01
Triage SBP (per 10 mm Hg) 1.14 (1.04–1.26) 0.002 0.89 (0.69–1.14) 0.34 1.19 (1.01–1.39) 0.04
Triage DBP (per 10 mm Hg) 1.09 (0.97–1.23) 0.08 0.85 (0.70–1.04) 0.11 1.30 (1.08–1.57) 0.007
Pharmaceutical treatment of 
blood pressure in eD
6.05 (1.80–20.31) 0.003 3.53 (0.40–31.0) 0.26 11.00 (1.43–84.40) 0.02
Reassessment protocol in eD 2.49 (1.77–3.50) <0.0001 4.11 (2.55–6.58) <0.0001 1.93 (1.08–3.41) 0.03
Care provided by attending only  
(vs. attending and medical  
student/resident)
1.77 (1.29–2.42) 0.001 2.03 (1.36–3.05) 0.001 1.26 (0.71–2.24) 0.41
CI, confidence interval; DBP, diastolic blood pressure; ED, emergency department; SBP, systolic blood pressure.
aBlacks were compared to whites only. There were 434 self-identified blacks and 773 self-identified whites. The 10 Asian and 33 “other race” subjects were not included in the 
logistic regression. bPatients with chest pain, shortness of breath, and neurologic complaints were considered symptomatic and were compared to those without these symptoms 
(considered asymptomatic). A neurologic complaint was defined a priori as focal weakness, sensory changes, disequilibrium, vision changes, and headache.
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that health-care providers may rely on different factors when 
deciding to conduct a BP reassessment.
Our data additionally demonstrated a disconnect between 
health-care provider self-report and practice, with an exagger-
ated self-reported threshold for BP reassessment by providers. 
Overall, the mean BP values obtained from providers were higher 
than those obtained from the medical record review. Given that 
only 57% of patients actually had a BP reassessment, however, 
these findings are less encouraging than they initially appear.
Physicians also overestimated their referral practices. Of 
the 1,066 patients with an initial or mean SBP ≥140 mm Hg 
or DBP ≥90 mm Hg, only 10% were provided a directed refer-
ral at discharge, with the majority of referrals occurring in 
patients with higher BP values. Factors most highly associated 
with outpatient referral included pharmaceutical treatment of 
elevated BP during the ED visit, the presence of an ED-based 
BP reassessment protocol and completion of a BP reassess-
ment. These findings suggest that active interventions, be 
they  physician-initiated or protocol-driven, may be the most 
 effective in prompting health-care providers to  recommend 
outpatient follow-up.
Aside from outpatient referral, the provision of a prescription 
for antihypertensive medications was the most common dis-
charge intervention and occurred most frequently in patients 
with higher BP elevations as well as those with a prior history 
of hypertension. Providing a prescription renewal for known 
hypertensive patients may be appropriate, however, the initia-
tion of an antihypertensive medication in “newly diagnosed” 
table 3 | Minimum mean blood pressure reassessment 
thresholds for asymptomatic patients
BP (mm Hg)a
Nurses  
(n = 224)
Physicians  
(n = 155)
Medical record 
(n = 434)b P value
All sites
 Systolic  
 (95% CI)
162 (159–165) 169 (166–172) 159 (157–161) <0.0001
 Diastolic  
 (95% CI)
95 (94–96) 100 (99–101) 92 (91–93) <0.0001
Sites without a reassessment protocol
 Systolic  
 (95% CI)
162 (158–166) 168 (164–172) 156 (154–159) <0.0001
 Diastolic  
 (95% CI)
95 (93–97) 99 (98–101) 92 (90–93) <0.0001
Sites with a reassessment protocol
 Systolic  
 (95% CI)
162 (158–166) 170 (166–174) 162 (160–165) 0.04
 Diastolic  
 (95% CI)
95 (94–97) 100 (98–102) 91 (90–93) <0.0001
BP, blood pressure; CI, confidence interval.
aNurse and physician BP thresholds are presented as mean self-reported values. The 
medical record threshold value is the mean of the initial BP documented in the medical 
records of patients who actually underwent a BP reassessment. bOnly asymptomatic 
patients were included.
table 4 | Factors associated with a referral for outpatient blood 
pressure follow-up
Variable
All patients (n = 1,250)
Adjusted odds ratio 
(95% CI) P value
Demographic factors
 Female sex 0.90 (0.55–1.48) 0.66
 Age, per 10 years 1.00 (0.84–1.19) 0.99
 Blacka 1.92 (1.11–3.34) 0.02
 Hispanic 1.75 (0.87–3.54) 0.12
History of hypertension 1.19 (0.59–2.40) 0.63
Currently taking 
antihypertensive medication
0.70 (0.34–1.43) 0.33
Alcohol use 1.00 (0.98–1.01) 0.36
Cocaine use 1.00 (0.99–1.01) 0.50
Symptomsb
 Chest pain 1.64 (0.83–3.22) 0.16
 Shortness of breath 0.44 (0.17–1.17) 0.10
 neurologic complaint 1.30 (0.71–2.38) 0.40
Mean SBP (per 10 mm Hg) 1.28 (1.08–1.51) 0.004
Mean DBP (per 10 mm Hg) 1.24 (0.96–1.59) 0.10
Pharmaceutical treatment of 
blood pressure in eD
5.55 (2.72–11.32) <0.0001
Reassessment protocol in eD 2.58 (1.32–5.05) 0.006
BP repeated during eD visit 2.56 (1.34–4.89) 0.004
Care provided by attending 
only (vs. attending and medical 
student/resident)
1.50 (0.88–2.55) 0.08
DBP, diastolic blood pressure; ED, emergency department; SBP, systolic blood pressure.
aBlacks were compared to whites only. There were 434 self-identified blacks and 773 
self-identified whites. The 10 Asian and “33” other race subjects were not included in 
the logistic regression. bPatients with chest pain, shortness of breath, and neurologic 
complaints were considered symptomatic and were compared to those without these 
symptoms (considered asymptomatic). A neurologic complaint was defined a priori as 
focal weakness, sensory changes, disequilibrium, vision changes, and headache.
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Figure 1 | Proportion of asymptomatic patients (mean SBP ≥160 or 
DBP ≥100 mm Hg) receiving a directed referral: physician self-report 
vs. practice. Physicians were asked what percentage of the time they 
refer an asymptomatic patient with the stated BP values. Medical record 
review obtained the proportion of patients with SBP ≥160 mm Hg or DBP 
≥100 mm Hg who received an outpatient referral. DBP, diastolic blood 
pressure; SBP, systolic blood pressure. *219 patients had an SBP ≥160 mm Hg. 
†111 patients had a DBP ≥100 mm Hg.
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patients is not supported by established or American College 
of Emergency Physicians guidelines.2,13 Until more data exist, 
the initiation of any antihypertensive medication from the ED 
remains controversial, particularly when not accompanied by 
dietary and lifestyle modification recommendations.13
limitations
The exclusion of patients who were admitted to the hospital 
may have altered our prevalence estimates of patients with ele-
vated BP. This exclusion was necessary because one of our sec-
ondary end points was the provision of a directed referral to 
patients at discharge. An additional limitation was the catego-
rization of symptomatic patients. In this investigation, patients 
presenting with chest pain, shortness of breath, or a neurologic 
complaint were categorized as symptomatic. These symptoms 
may or may not have been related to patients’ elevated BPs, 
which would have led to a misclassification error.
The medical record review provided three additional limi-
tations. First, we were unable to compare directly individual 
health-care provider self-report of reassessment or referral to 
his/her actual practice, limiting our ability to formally test our 
data. Second, we were unable to determine who obtained BP 
reassessments and why: A physician’s verbal order for a repeat 
BP assessment may have been documented only in the nursing 
notes. Alternatively, a repeat BP assessment may have been ini-
tiated by a nurse, yet documented only by the physician. Finally, 
we were unable to capture any verbal  recommendations that 
were in addition to those documented in patients’ discharge 
instructions. The only means to improve data quality would 
have been to conduct a prospective investigation, with study 
personnel recording individual health-care provider behaviors 
in real time. This alternative is less satisfactory than our origi-
nal research plan because provider behavior would likely have 
been influenced by the Hawthorne effect: With time, providers 
would have realized that their reassessment and referral prac-
tices were being recorded, and we suspect that this realization 
would have led to an artificial increase in such practices.
In conclusion, our results demonstrate infrequent reassess-
ment and referral of ED patients with elevated BP. We further 
demonstrated that health-care providers overestimate their 
reassessment and referral efforts. Given our sample characteris-
tics, ED screening has great potential to capture at-risk patients, 
the relatively young, socioeconomically disadvantaged, and 
minorities. For current preventative and emergency medicine 
hypertension screening recommendations to be implemented 
in the ED setting, this disconnect between provider self-report 
and practice requires further investigation.1,2,13,34
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